ANCO’s ASCO Highlights 2019
H

ANCO's ASCO Update on Breast Cancer - Margetuximab + Chemo Improves PFS in HER2+ Breast Cancer & OS Benefit of Adding Atezolizumab to Nab-Paclitaxel in TNBC

By ANCO’s ASCO Highlights 2019 FEATURING Helen K. Chew
By ANCO’s ASCO Highlights 2019 FEATURING Helen K. Chew
122 views
September 12, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
49:07
SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo
17:35
Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
13:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…

Feat. S. Hurvitz
05:45
SABCS 2022 Conference Coverage

SABCS 2022 Adjuvant Paclitaxel & Trastuzumab for Node- HER2+ BC:…

Feat. S. Tolaney
11:19
Adam Brufsky

HER2+ mBC: The Role of TDM-1

07:34
PrecisCa

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

Feat. M. Pegram
07:49
UChicago Medicine

Antibody Drug Conjugates: Overview and Background of a Revolution in…

Feat. H. Rugo
22:49
Oncology Data Advisor

Highlights of the 2023 SABCS: HER2CLIMB-02, MONARCH3, and INAVO120 T…

Feat. J. Mouabbi
26:30
Insights from 2023 SABCS

SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & H…

Feat. S. Tolaney, H. Rugo
11:10
Dana-Farber Cancer Institute

Antibody Drug Conjugates in Breast Cancer

Feat. S. Tolaney
10:54
Yale Cancer Center

De-Escalation of Adjuvant Therapy in Early Stage HER2+ Breast Cancers

Feat. L. Pusztai
26:28
2023 West Oncology Conference

Antibody Drug Conjugates for Breast Cancer: The End of Chemotherapy?

Feat. L. Schwartzberg
12:13
UChicago Medicine

Trastuzumab Deruxtecan in HER2+ mBC

Feat. H. Rugo
08:41
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III…

Feat. P. Conte
21:44
Yale Cancer Center

Updates on Metastatic Breast Cancer - Yale Cancer Center

Feat. D. O'Neil
09:52
Insights from 2023 SABCS

SABCS 2023 Insights: "HER2CLIMB-02 Trial of Tucatinib & Tra…

Feat. S. Hurvitz